US equities
|
SPCX
$167.62
▲+5.44%
NVDA
$237.25
▲+1.41%
MU
$1,065.31
▼-0.89%
TSLA
$377.93
▲+1.98%
MSFT
$525.38
▲+1.52%
SNDK
$1,708.51
▼-0.67%
INTC
$117.00
▼-1.96%
META
$743.94
▲+2.18%
SPCX
$167.62
▲+5.44%
NVDA
$237.25
▲+1.41%
MU
$1,065.31
▼-0.89%
TSLA
$377.93
▲+1.98%
MSFT
$525.38
▲+1.52%
SNDK
$1,708.51
▼-0.67%
INTC
$117.00
▼-1.96%
META
$743.94
▲+2.18%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
MoonLake Immunotherapeutics - Class A Ordinary Shares
(NQ:
MLTX
)
11.61
+0.20 (+1.75%)
Delayed Quote
Updated: 1:05 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MoonLake Immunotherapeutics - Class A Ordinary Shares
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX
October 15, 2025
From
DJS Law Group
Via
Business Wire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
October 15, 2025
From
The Schall Law Firm
Via
Business Wire
MOONLAKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics and Encourages Investors to Contact the Firm
October 15, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades
↗
September 29, 2025
Via
Stocktwits
MLTX Investor News: If You Have Suffered Losses in MoonLake Immunotherapeutics (NASDAQ: MLTX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
October 13, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
MOONLAKE IMMUNOTHERAPEUTICS REMINDER: Bragar Eagel & Squire, P.C. Urges Investors in MoonLake to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
October 09, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MLTX Investor News: If You Have Suffered Losses in MoonLake Immunotherapeutics (NASDAQ: MLTX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
October 09, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
MLTX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
October 08, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
MOONLAKE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into MoonLake Immunotherapeutics and Encourages Investors to Contact the Firm
October 07, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Which stocks have an unusual volume on Monday?
↗
October 06, 2025
Volume analysis on 2025-10-06: stocks with an unusual volume in today's session.
Via
Chartmill
Top 3 Health Care Stocks That Are Preparing To Pump In Q4
↗
October 06, 2025
Via
Benzinga
MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
October 05, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
MLTX Investor News: If You Have Suffered Losses in MoonLake Immunotherapeutics (NASDAQ: MLTX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
October 03, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Unusual volume stocks are being observed in Friday's session.
↗
October 03, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via
Chartmill
Unusual volume stocks are being observed in Thursday's session.
↗
October 02, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
MOONLAKE ALERT: Bragar Eagel & Squire, P.C. Announces Investigation into MoonLake Immunotherapeutics on Behalf of MoonLake Stockholders and Encourages Investors to Contact the Firm
October 02, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX
October 01, 2025
From
DJS Law Group
Via
Business Wire
MoonLake Investor News: Rosen Law Firm Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – MLTX
October 01, 2025
From
Rosen Law Firm
Via
Business Wire
MLTX Investors Have Opportunity to Join MoonLake Immunotherapeutics Fraud Investigation with the Schall Law Firm
October 01, 2025
From
Schall Law Firm
Via
Business Wire
Unusual volume stocks are being observed in Wednesday's session.
↗
October 01, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
MoonLake Immunotherapeutics Stock Draws Wall Street Attention Post Monday’s Plunge: Retail Sees Significant Upside
↗
September 30, 2025
Needham analyst Serge Belanger lowered the firm's price target on the stock to $20 from $66 but kept a ‘Buy’ rating on the shares.
Via
Stocktwits
MLTX INVESTIGATION ALERT: MoonLake Immunotherapeutics Trial Results Triggers Securities Fraud Investigation after Stock Plummets 90% -- Investors Urged to Contact BFA Law
September 30, 2025
From
Bleichmar Fonti & Auld LLP
Via
Business Wire
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
September 30, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Wall Street Lights Up as Cannabis Stocks Blaze Higher, Biotech Melts Down
↗
September 30, 2025
U.S. markets kicked off the week quietly, but certain stocks were anything but dull. Cannabis names surged after a Trump-endorsed CBD video went viral, while biotech firm MoonLake was crushed by...
Via
Chartmill
Topics
Cannabis
Wolfspeed, Tilray, Robinhood, Etsy, And Moonlake Immunotherapeutics: Why These 5 Stocks Are On Investors' Radars Today
↗
September 29, 2025
U.S. stocks advanced today, with the Nasdaq climbing about 107 points, or 0.48%, to 22,591.15. The S&P 500 added 0.26% to close at 6,661.21, while the Dow Jones Industrial Average edged up 0.15% to...
Via
Benzinga
Topics
Stocks
Crude Oil Falls Sharply; Carnival Posts Upbeat Earnings
↗
September 29, 2025
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Monday. The Dow traded down 0.12% to 46,190.92 while the NASDAQ rose 0.40% to 22,574.89. The S&P 500...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 29, 2025
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44....
Via
Benzinga
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
September 29, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
Nasdaq Jumps 150 Points; US Pending Home Sales Rise
↗
September 29, 2025
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.19% to 46,333.68 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
MoonLake Crashes 89% On Mixed Results For Skin Disease Treatment
↗
September 29, 2025
MoonLake Immunotherapeutics stock crashed Monday after the company posted mixed results for its skin disease drug.
Via
Investor's Business Daily
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
